BRAINSTORM CELL THERAPEUTICS INC.·4

Jan 3, 5:31 PM ET

HARTOUNIAN HARTOUN 4

4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-01
HARTOUNIAN HARTOUN
EVP, Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-01-01+50,00052,000 total
Footnotes (2)
  • [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
  • [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Documents

1 file
  • 4
    tm251864-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT